Medplus Health Services Ltd. · NSE:MEDPLUS

Medplus Health Services — Q1 FY27 Earnings Presentation

24 slides from Medplus Health Services's earnings presentation, Jul 21, 2026

  1. Slide 1: MedPlus Health Services Limited exchange filing cover letter

    MedPlus Health Services Limited July 21, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Mumbai 400 001 Bandra (East), Mumbai – 400 051 BSE Scrip Code: 543427 N

  2. Slide 2: Performance – Q1 FY27

    Retum on Investment = adpscing / £ Comal aie accumsan, / Performance — Q1 FY27

  3. Slide 3: FY27 Q1 Executive Summary

    FY27 Q1 Executive Summary ➢ Revenue has grown by 21.8% from ₹ 15,426 million in Q1 FY26 to ₹ 18,796 million in Q1 FY27 ➢ During the quarter 146 new stores have been added (including 131 new franchisees) ➢ Gross margin decreased by 160 bps from 26.1% in Q1 FY26 to 24.5% in Q1 FY27 ➢ Operating EBITDA

  4. Slide 4: Income Statement: All Segments ₹m

    Income Statement : All Segments ₹m Q1 FY27 AOP Particulars Q1 FY27 Q1 FY26 Q4 FY26 YoY QoQ AOP Variance Revenue 18,796.0 15,426.3 18,643.8 18,993.5 21.8% 0.8% -1.0% - Revenue for Q1FY27 has grown by 21.8% YoY and QoQ has grown by 0.8% Gross Margin 4,603.1 4,029.0 4,934.4 4,913.9 14.3% -6.7% -6.3% Gr

  5. Slide 5: Income Statement: Pharmacy ₹m

    Income Statement : Pharmacy ₹m Q1 FY27 AOP Particulars Q1 FY27 Q1 FY26 Q4 FY26 YoY QoQ AOP Variance - Revenue for Q1FY27 has grown by 21.8% YoY and QoQ Revenue 18,398.7 15,106.4 18,265.9 18,599.6 21.8% 0.7% -1.1% has grown by 0.7% Gross Margin 4,282.0 3,772.6 4,627.5 4,597.2 13.5% -7.5% -6.9% - Gros

  6. Slide 6: Revenue by category

    Revenue by category ₹ million Particulars FY25Q1 FY25Q2 FY25Q3 FY25Q4 FY25 FY26Q1 FY26Q2 FY26Q3 FY26Q4 FY26 FY27Q1 Branded Pharma 10,333 10,594 10,330 9,543 40,800 9,987 10,736 11,245 11,598 43,566 11,981 Branded Non Pharma 1,672 1,679 1,620 1,424 6,395 1,421 1,463 1,627 1,634 6,146 1,665 Pvt Label

  7. Slide 7: Market Estimates vs Performance

    Market Estimates vs Performance ₹ million Axis Cap Nuvama Spark HDFC Sec Elara Cap MedPlus Revenue 18,512.0 18,203.0 18,737.0 18,510.0 18,112.0 18,796.0 Cost of sales 14,192.9 Gross Profit 4,603.1 Gross Margin % 24.5% Op.EBITDA 608.0 651.2 Op.EBITDA % 3.3% 3.1% 3.5% EBITDA 1,204.0 1,264.0 1,203.0 1,

  8. Slide 8: Network of 5,476 Pharmacies

    Network of 5,476 Pharmacies1… 5600 - Network of stores as on 30th June 2026 is 146 5476 5,476 (COCO stores 4,812 and Franchisee stores 664) 5400 218 5330 - Net addition of 146 stores in Q1FY27 5200 (Q1FY26 101) 182 5000 Kolkata 315 - Operating in 850+ Cities and towns, covering 117 1 2,520+ PIN code

  9. Slide 9: Q1 FY27 Performance by Cohort

    Q1 FY27 Performance by Cohort # Pharmacies Revenue, ₹m Store EBITDA, ₹m 112, 2% 1031, 6% 132, 1% 19, 1% -18, -1% 442, 9% 879, 5% 62, 4% 3321, 13936, 143, 8% 1499, 69% 79% 86% 335, 7% 1563, 9% 602, 13% UptoFY23 FY24 FY25 FY26 FY27 Upto FY23 FY24 FY25 FY26 FY27 Upto FY23 FY24 FY25 FY26 FY27 Cohort Sto

  10. Slide 10: Pharmacy EBITDA – Q1 FY27 (Cause of change)

    Pharmacy EBITDA – Q1 FY27 (Cause of change) Operating EBITDA YoY, ₹m Operating EBITDA QoQ, ₹m 1,100 509 1,022 1,000 900 -297 800 700 690 -208 -345 12 588 60 588 600 -63 -1 -43 -94 -24 500 -43 400 300 - Operating EBITDA margin decreased by ~14% YoY from 4.6% to 3.2% - Operating EBITDA margin decrease

  11. Slide 11: COCO Stores: 4,812 Stores

    COCO Stores: 4,812 Stores Revenue, ₹m PL Mix% 17,326 17,409 16,882 24.2% 15,850 23.8% 23.6% 15,176 22.6% 23.0% 15,014 14,731 21.6% 14,473 20.4% 19.1% 10.1% 9.1% 10.2% 11.3% 11.4% 8.6% 10.1% 8.2% 14.1% 13.4% 12.8% 11.8% 12.4% 12.2% 11.5% 11.0% PL P% PL NP% PL% Slab wise Bills in Thousands Slab wise R

  12. Slide 12: COCO Stores: 4,812 Stores

    COCO Stores: 4,812 Stores Gross Margin & Discount Store Level EBITDA and EBITDA% 12.6% 12.0% 11.2% 11.5% 2,177 27.3% 10.5% 10.5% 27.1% 9.8% 2,028 9.8% 26.8% 26.4% 26.0% 1,817 25.9% 1,582 1,616 1,551 1,705 - SL EBITDA 9.8% in FY27Q1 (PY:10.5%) 1,486 24.2% 23.4% - Out of 2,658 stores which are below 9

  13. Slide 13: COCO Stores: 4,812 Stores

    COCO Stores: 4,812 Stores SSSG ₹ million Net Revenue Net Growth Cohort Stores# FY27Q1 FY26Q1 FY26Q4 YoY YoY% QoQ QoQ% Upto FY23 3321 13,729.4 12,236.9 13,928.1 1,492.5 12% -198.78 -1.4% FY24 602 1,521.3 1,196.9 1,514.8 324.3 27% 6.48 0.4% FY25 335 871.6 601.0 860.4 270.6 45% 11.20 1.3% FY26 442 1,02

  14. Slide 14: KPIs by Cohort: New Stores Revenue Ramp up FY26 & FY27

    KPIs’ by Cohort: New Stores Revenue Ramp up FY26 & FY27 Cohort Stores# Month-1 Month-3 Month-6 Month-9 Month-12 Month-15 Apr-25 18 17,596 14,484 19,174 23,660 25,272 25,714 May-25 15 14,591 23,613 32,317 36,965 37,793 Jun-25 39 6,454 17,241 23,076 25,137 24,612 Jul-25 16 29,452 17,846 25,574 28,581

  15. Slide 15: KPIs by Cohort: FY26 & FY27 – SL EBITDA% Ramp up

    KPIs’ by Cohort: FY26 & FY27 – SL EBITDA% Ramp up Cohort Stores# Month-3 Month-6 Month-9 Month-12 Month-15 Apr-25 18 -4.6% 3.3% 7.4% 10.9% 7.5% May-25 15 1.4% 8.1% 10.1% 8.8% Jun-25 39 -2.2% 5.0% 5.8% 4.2% Jul-25 16 -6.0% 3.4% 8.3% 3.2% Aug-25 18 -3.0% 1.9% 1.1% Sep-25 49 -1.4% 4.0% 5.1% Oct-25 19 -

  16. Slide 16: Diagnostics performance update

    Diagnostics performance update 14

  17. Slide 17: Income Statement Diagnostics ₹m

    Income Statement Diagnostics ₹m Q1 FY27 AOP Particulars Q1 FY27 Q1 FY26 Q4 FY26 YoY QoQ AOP Variance Revenue 370.8 302.9 347.8 368.1 22.4% 6.6% 0.7% Cost of Material Consumed 66.7 57.7 62.2 67.8 15.6% 7.1% -1.7% Center Level Expenses 183.3 153.8 177.2 186.3 19.2% 3.5% -1.6% Salaries 64.0 47.4 62.2 6

  18. Slide 18: Capex AOP vs Actual

    Capex AOP vs Actual = MedPlus&

  19. Slide 19: Capex AOP vs Actual

    Capex AOP vs Actual ₹ million Particulars FY27 FY27 Q1 FY27 Q1 AOP AOP Actual New COCO Stores 700.0 145.0 126.3 New FOFO Stores 400.0 100.0 New Warehouses 80.0 80.0 26.6 Stores Renovation 500.0 125.0 14.7 Maintenance Capex (Optival) 120.0 30.0 153.6 Factories Capex (Optival) 5.0 1.3 - Factories Cape

  20. Slide 20: Thank you.

    Thank you. MedPlus& 18

  21. Slide 21: Annexures

    Annexures MedPlus& 19

  22. Slide 22: Performance vs AOP (Summary)

    Performance vs AOP (Summary) Actuals AOP Achievement Particulars Q1 FY27 FY27 Q1 FY27 Q2 FY27 Q3 FY27 Q4 FY27 FY27 Q1 FY27 Q2 FY27 Q3 FY27 Q4 FY27 FY27 Revenue 18,796 18,796 18,993 20,797 21,955 22,546 84,290 99.0% 0.0% 0.0% 0.0% 22.3% Consolidated Shoplevel Expenses 2,696 2,696 2,818 2,919 3,036 3,

  23. Slide 23: KPIs

    KPIs’ : Sales per day per store ₹ Days of Inventory 45,582 98 43,762 44,944 94 40,608 41,151 94 39,846 38,849 38,765 28,506 76 27,235 27,355 70 25,731 73 23,320 63 63 20,983 21,152 21,268 21,427 28,399 61 26,542 27,219 23,228 23,284 25,471 51 21,107 51 19,615 46 47 18,100 18,219 45 16,015 42 14,081

  24. Slide 24: Diagnostic Center wise Income Statement ₹m – Q1FY27

    Diagnostic Center wise Income Statement ₹m – Q1FY27 Hyd Hyderabad Chennai Srinagar Vijaynagar Vanasthalipu Particulars Gachibowli Habsiguda Kompally Kukatpally Nallagandla Dilsukhnagar Miyapur Banjara Hills AS Rao Nagar Standalone Collection Collection Total Colony Colony ram CCs centers centers No

MedPlus Health Services — Q1 FY27 Earnings Presentation on 6ix